Historique
![Cyclopropylfentanyl. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide in the framework of the Council Decision on new psychoactive substances](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_80916.webp?v=1771274389)
Rapport
Cyclopropylfentanyl. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide in the framework of the Council Decision on new psychoactive substances
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction)
Année
2018
Page(s) :
58 p.
Langue(s) :
Anglais
Collection :
Risk assessments, 29
ISBN :
978-92-9497-351-1
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Organismes
OEDT
Thésaurus mots-clés
FENTANYL
;
CONTROLE DES STUPEFIANTS
;
FACTEUR DE RISQUE
;
DROGUES DE SYNTHESE
;
PHARMACOLOGIE
;
TYPE D'USAGE
;
EFFET SECONDAIRE
;
TOXICITE
;
INTOXICATION
;
MORTALITE
Thésaurus géographique
EUROPE
Note de contenu :
Foreword.
EMCDDA actions on monitoring and responding to new drugs.
EMCDDA-Europol Joint Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl): a summary.
Risk Assessment Report of a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl).
Annex 1: Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl).
Participants of the risk assessment meeting.
EMCDDA actions on monitoring and responding to new drugs.
EMCDDA-Europol Joint Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl): a summary.
Risk Assessment Report of a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl).
Annex 1: Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl).
Participants of the risk assessment meeting.
Résumé :
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. On the basis of the Risk Assessment Report - and on the initiative of the European Commission - on 27 September 2018, the Council decided that cyclopropylfentanyl should be subject to control measures across the Member States.